< Back to companies

Enzyre is a UMC St. Radboud spin-off company which officially started in March 2017. It was founded with the mission to develop innovative diagnostic solutions to enable personalized medicine. The company holds the vision to create a point of care (POC) diagnostic platform that will measure a multitude of enzymatic reactions based on chemiluminescence.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2016
Website
enzyre.com/

Categories

Monitoring DevicesDevice DevelopmentMedical Devices
Only accessible to MedStartr community members. Join now

What do you think of Enzyre?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now